Compounds > cotinine

cotinine and Acute Relapsing Multiple Sclerosis

cotinine has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Barkhof, F; Brouwer, I; Bru, A; Bø, L; Edland, A; Eikeland, R; Gosal, S; Harbo, HF; Holmøy, T; Kleveland, G; Kvistad, SS; Lie, IA; Midgard, R; Myhr, KM; Sørenes, YS; Torkildsen, Ø; Vrenken, H; Wergeland, S; Wesnes, K; Øksendal, N1
Ascherio, A; Barro, C; Cortese, M; Edan, G; Foley, FW; Fox, EJ; Freedman, MS; Hartung, HP; Hemmer, B; Kappos, L; Kuhle, J; Martínez-Lapiscina, EH; Montalbán, X; Munger, KL; Penner, IK; Schippling, S; Wicklein, EM1

Trials

1 trial(s) available for cotinine and Acute Relapsing Multiple Sclerosis

ArticleYear
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
    Neurology, 2020, 05-05, Volume: 94, Issue:18

    Topics: Adjuvants, Immunologic; Antibodies, Viral; Biomarkers; Cognition; Cotinine; Demyelinating Diseases; Double-Blind Method; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Interferon beta-1b; Male; Multiple Sclerosis, Relapsing-Remitting; Neurofilament Proteins; Risk Factors; Smoking; Time; Vitamin D

2020

Other Studies

1 other study(ies) available for cotinine and Acute Relapsing Multiple Sclerosis

ArticleYear
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.
    Neurology(R) neuroimmunology & neuroinflammation, 2022, Volume: 9, Issue:5

    Topics: Atrophy; Cotinine; Gray Matter; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Retrospective Studies; Smoking

2022